DongKoo Bio & Pharma Co., Ltd.
KOSDAQ
₩3,500.00
-0.14%
Delayed · cached 15 min
Fair value analysis
006620
DongKoo Bio & Pharma Co., Ltd.
₩3,500.00
Close used for this calculation
₩9,937.33Fair value
Financial DNA Score
Profitability · Returns · Balance Sheet · Efficiency · Growth
71/100
Quality radar
Consensus fair value
₩9,937.33
Below FV▲ +183.9% against the close used
Model range ₩4,082.40 – ₩38,302.42
The lowest and highest of the models that produced a value. This is the spread of the methods, not a price target.
Price target range & 52-week position
Bear₩4,082.40Fair value₩9,937.33Bull₩38,302.42
FairClose
52-week traded range
52W low ₩3,450.0052W high ₩6,090.00
The 52-week range is measured from the stored price history, not estimated.
Valuation summary
Trading below the consensus fair value
DongKoo Bio & Pharma Co., Ltd. closed at ₩3,500.00, 64.8% below the consensus fair value of ₩9,937.33 drawn from 3 valuation models.
Financial DNA score 71/100 — Strong. P/E of 1.9x against the 20x sector multiple the P/E model uses.
Quantitative summary only — not investment advice.
All valuation models
EV/EBITDA
₩9,937.33
+183.9%
(EBITDA × 18x − Net Debt) ÷ Shares
EBITDA=15.72B
Dividend Discount (DDM)
₩4,082.40
+16.6%
D1 ÷ (r − g) where D1 = D0×(1+g)
D0=75.6, r=10%, g=8%
Book Value (P/B)
₩38,302.42
+994.4%
BVPS × (ROE−g)÷(r−g) [Justified P/B — RIM-based]
BVPS=5645.16, ROE=33.1%, g=6%, r=10%
Computed on September 12, 2026 from the most recent annual report on file and that day's closing price. Where a company has seen its earnings move sharply since its last annual report, this figure will lag the market.
Educational data only. Not a recommendation to buy, sell or hold any security.